These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30028196)

  • 1. FGF23 impairs peripheral microvascular function in renal failure.
    Verkaik M; Juni RP; van Loon EPM; van Poelgeest EM; Kwekkeboom RFJ; Gam Z; Richards WG; Ter Wee PM; Hoenderop JG; Eringa EC; Vervloet MG;
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1414-H1424. PubMed ID: 30028196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease.
    Tatematsu S; Wakino S; Kanda T; Homma K; Yoshioka K; Hasegawa K; Sugano N; Kimoto M; Saruta T; Hayashi K
    J Am Soc Nephrol; 2007 Mar; 18(3):741-9. PubMed ID: 17267746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes.
    Verkaik M; Oranje M; Abdurrachim D; Goebel M; Gam Z; Prompers JJ; Helmes M; Ter Wee PM; van der Velden J; Kuster DW; Vervloet MG; Eringa EC;
    Physiol Rep; 2018 Apr; 6(7):e13591. PubMed ID: 29611320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease.
    Kirkman DL; Muth BJ; Ramick MG; Townsend RR; Edwards DG
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F423-F429. PubMed ID: 29117995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner.
    Graves JM; Vallejo JA; Hamill CS; Wang D; Ahuja R; Patel S; Faul C; Wacker MJ
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2283-H2294. PubMed ID: 33929896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.
    Silswal N; Touchberry CD; Daniel DR; McCarthy DL; Zhang S; Andresen J; Stubbs JR; Wacker MJ
    Am J Physiol Endocrinol Metab; 2014 Sep; 307(5):E426-36. PubMed ID: 25053401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important Role of Endothelial Caveolin-1 in the Protective Role of Endothelium-dependent Hyperpolarization Against Nitric Oxide-Mediated Nitrative Stress in Microcirculation in Mice.
    Saito H; Godo S; Sato S; Ito A; Ikumi Y; Tanaka S; Ida T; Fujii S; Akaike T; Shimokawa H
    J Cardiovasc Pharmacol; 2018 Feb; 71(2):113-126. PubMed ID: 29419573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
    Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
    Shalhoub V; Shatzen EM; Ward SC; Davis J; Stevens J; Bi V; Renshaw L; Hawkins N; Wang W; Chen C; Tsai MM; Cattley RC; Wronski TJ; Xia X; Li X; Henley C; Eschenberg M; Richards WG
    J Clin Invest; 2012 Jul; 122(7):2543-53. PubMed ID: 22728934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial C-Type Natriuretic Peptide Acts on Pericytes to Regulate Microcirculatory Flow and Blood Pressure.
    Špiranec K; Chen W; Werner F; Nikolaev VO; Naruke T; Koch F; Werner A; Eder-Negrin P; Diéguez-Hurtado R; Adams RH; Baba HA; Schmidt H; Schuh K; Skryabin BV; Movahedi K; Schweda F; Kuhn M
    Circulation; 2018 Jul; 138(5):494-508. PubMed ID: 29626067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells.
    Richter B; Haller J; Haffner D; Leifheit-Nestler M
    Pflugers Arch; 2016 Sep; 468(9):1621-35. PubMed ID: 27448998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic Overactivity in CKD Disrupts Buffering of Neurotransmission by Endothelium-Derived Hyperpolarizing Factor and Enhances Vasoconstriction.
    Cao W; Wu L; Zhang X; Zhou J; Wang J; Yang Z; Su H; Liu Y; Wilcox CS; Hou FF
    J Am Soc Nephrol; 2020 Oct; 31(10):2312-2325. PubMed ID: 32616538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.
    Durlacher-Betzer K; Hassan A; Levi R; Axelrod J; Silver J; Naveh-Many T
    Kidney Int; 2018 Aug; 94(2):315-325. PubMed ID: 29861060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary and Peripheral Vasomotor Responses to Mental Stress.
    Hammadah M; Kim JH; Al Mheid I; Samman Tahhan A; Wilmot K; Ramadan R; Alkhoder A; Khayata M; Mekonnen G; Levantsevych O; Bouchi Y; Kaseer B; Choudhary F; Gafeer MM; Corrigan FE; Shah AJ; Ward L; Kutner M; Bremner JD; Sheps DS; Raggi P; Vaccarino V; Samady H; Mavromatis K; Quyyumi AA
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: insight into ischemia-induced reduction in endothelium-dependent vasodilatation.
    Laham RJ; Simons M; Tofukuji M; Hung D; Sellke FW
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1022-8. PubMed ID: 9832695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine.
    Kajimoto H; Kai H; Aoki H; Yasuoka S; Anegawa T; Aoki Y; Ueda S; Okuda S; Imaizumi T
    Kidney Int; 2012 Apr; 81(8):762-8. PubMed ID: 22297680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginase Inhibition Improves Microvascular Endothelial Function in Patients With Type 2 Diabetes Mellitus.
    Kövamees O; Shemyakin A; Checa A; Wheelock CE; Lundberg JO; Östenson CG; Pernow J
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3952-3958. PubMed ID: 27399350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.
    Ni H; Chen J; Pan M; Zhang M; Zhang J; Chen P; Liu B
    J Mol Histol; 2013 Dec; 44(6):693-703. PubMed ID: 23907620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypericin Alleviates Chronic Kidney Disease-induced Left Ventricular Hypertrophy by Regulation of FGF23-FGFR4 Signaling Pathway.
    Liu M; Cheng L; Ye Q; Liu H; Shu C; Gao H; Liu X; Zhang X; Chen G
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):588-601. PubMed ID: 38547517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of mitochondrial dysfunction in hyperglycaemia-induced coronary microvascular dysfunction: Protective role of resveratrol.
    Joshi MS; Williams D; Horlock D; Samarasinghe T; Andrews KL; Jefferis AM; Berger PJ; Chin-Dusting JP; Kaye DM
    Diab Vasc Dis Res; 2015 May; 12(3):208-16. PubMed ID: 25767181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.